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ABSTRACT
We assessed the effect of geometric uncertainties on
target coverage and on dose to the organs at risk (OARs)
during intensity-modulated radiotherapy (IMRT) for
head-and-neck cancer, and we estimated the required
margins for the planning target volume (PTV) and the
planning organ-at-risk volume (PRV). For eight head-
and-neck cancer patients, we generated IMRT plans
with localization uncertainty margins of 0 mm,
2.5 mm, and 5.0 mm. The beam intensities were then
applied on repeat computed tomography (CT) scans
obtained weekly during treatment, and dose distri-
butions were recalculated.
The dose–volume histogram analysis for the re-
peat CT scans showed that target coverage was ad-
equate (V100 ³ 95%) for only 12.5% of the gross
tumour volumes, 54.3% of the upper-neck clinical
target volumes (CTVs), and 27.4% of the lower-neck
CTVs when no margins were added for PTV. The use
of 2.5-mm and 5.0-mm margins significantly im-
proved target coverage, but the mean dose to the con-
tralateral parotid increased from 25.9 Gy to 29.2 Gy.
Maximum dose to the spinal cord was above limit in
57.7%, 34.6%, and 15.4% of cases when 0-mm,
2.5-mm, and 5.0-mm margins (respectively) were
used for PRV.
Significant deviations from the prescribed dose
can occur during IMRT treatment delivery for head-
and-neck cancer. The use of 2.5-mm to 5.0-mm mar-
gins for PTV and PRV greatly reduces the risk of
underdosing targets and of overdosing the spinal cord.
KEY WORDS
IMRT, PTV margins, head and neck, geometric uncer-
tainties, 3D CRT
1. INTRODUCTION
Intensity modulated radiotherapy (IMRT) uses an op-
timized modulation of the beam fluences to generate
complex dose distributions that are characterized by
a high degree of conformity to the target volume and
greater sparing of normal tissue. In the treatment of
head-and-neck cancer, IMRT is used mainly to preserve
salivary function after radiotherapy 1–4 and to improve
dose coverage for complexly shaped tumours located
near critical structures 5–7. In addition, because IMRT
allows a higher dose to be delivered to the macro-
scopic tumour than to the area at risk for microscopic
disease within the same fraction, the IMRT technique
is ideally suited to the simultaneous delivery of inte-
grated-boost accelerated fractionation schemes 8,9.
Accounting for geometric uncertainties is an im-
portant issue with IMRT, because the isodose lines
conform tightly to the target volume. One approach
to compensate for set-up errors, organ motion, and
changes in target geometry consists of defining plan-
ning target volumes (PTV) for targets and planning
organ-at-risk volumes (PRV) for critical structures, as
recommended by the International Commission on
Radiation Units and Measurements (ICRU) 10,11. For
the head-and-neck region, the safety margins included
in the PTV are usually chosen to reflect expected set-
up uncertainties.
During treatment, portal imaging can be used to
assess the accuracy of field alignment. However, ac-
quiring port films for IMRT is often impractical be-
cause of the complex modulation of the beam
intensity. Thus, set-up verification for IMRT usually
consists of acquiring orthogonal images to check the
isocentre localization. Verification methods that rely
on this kind of two-dimensional imaging may not
provide a comprehensive overview of all the geo-
metric variations that can influence dose distribution
in an IMRT treatment. Slight variations in the patient’s
neck and shoulder positioning may not be properly
assessed, and some significant changes in shape be-
cause of a patient’s weight loss or tumour shrinkage
may not be detected. Furthermore, the effects of these
changes on the dose distribution are not as intuitive
during treatment with IMRT techniques. A proper PTV
and PRV definition for IMRT should not only focus on
the potential location of the target and the organs at
risk during treatment, but should also integrate any
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geometric variation in the surrounding tissue that may
result in significant deviation from the prescribed
dose.
In the present study, we assessed the effect of
geometric variations—including changes in patient
anatomy and set-up uncertainties—on the target cov-
erage and the dose to organs at risk by recalculating
IMRT dose distributions on repeat computed tomogra-
phy (CT) scans taken during treatment. In addition,
we generated IMRT plans using 2.5-mm and 5.0-mm
localization uncertainty margins to estimate the PTV
and PRV that would be effective in preventing signifi-
cant underdosing of the target volume and overdos-
ing of the critical structures.
2. PATIENTS AND METHODS
2.1 Patient Characteristics
We included 8 head-and-neck cancer patients con-
secutively treated with IMRT at our institution in this
dosimetric study. Primary tumour sites included
oropharynx (4 patients), nasopharynx (2 patients),
maxillary sinus (1 patient), and nodal metastasis from
an unknown primary (1 patient). All patients had
locally advanced stage III–IV(A) disease according to
the 2002 American Joint Committee on Cancer clas-
sification. In 7 patients, the treatment volume con-
sisted of comprehensive nodal irradiation (upper and
lower neck nodes), and 1 patient received treatment
to the primary tumour site and upper neck region only.
Two patients also received concurrent chemotherapy
with cisplatin.
2.2 CT Scans
Two weeks before the start of treatment, all patients
first underwent CT simulation in the treatment posi-
tion. To ensure proper immobilization and treatment
reproducibility, custom-made thermoplastic face
masks and shoulders pulls were used. The slice thick-
ness of the CT scan was 5 mm through the entire head
and neck region. Each patient then underwent repeat
CT scans at weekly intervals during treatment, with
the goal of obtaining at least four CT scans per pa-
tient. However, because of severe weight loss (3 pa-
tients) or significant shrinkage of a large neck mass
(1 patient), some patients required a new mask dur-
ing the course of treatment. In each of these cases, a
new IMRT plan was generated for the remainder of the
treatment. As a result, only the repeat CT scans that
were made with the initial mask were used for the
study. Thus, 4 patients had four repeat CT scans as
planned, 2 patients had three CT scans, and 2 patients
had two CT scans, for a total of 26 repeat CT scans. All
the repeat CT scans were acquired using the same CT
protocol that was used in the planning CT scans and
radio-opaque markers were placed on the thermoplas-
tic masks to indicate the treatment isocentre.
2.3 Contouring Target Volumes and OAR
The gross tumour volume (GTV), clinical target vol-
ume (CTV), and organs at risk (OARs) were contoured
on the initial planning CT scan according to ICRU defi-
nitions. The primary tumour and each positive node
were delineated as separate volumes, except when
they were immediately adjacent. The CTV was defined
as any potential area of microscopic disease and usu-
ally included a margin of at least 1 cm around the
GTV to account for direct tumour invasion (except
when it was adjacent to structures known not to be
involved), plus the lymph-node regions at risk. For
dose prescription and DVH analysis, the upper and
lower nodal neck regions were contoured separately.
The normal structures that were defined were the
spinal cord and brain stem, the ipsilateral and con-
tralateral parotids, the mandible, and the larynx. The
target volumes (GTV and CTV) and OARs were then re-
drawn on all the repeat CT scans by a single radiation
oncologist. An anatomy-matching fusion algorithm
semiautomatically matched the original with the re-
peat CT scans so that the original targets were super-
imposed on the repeat CT scans. The target contours
were then modified with respect to changes in pa-
tient anatomy.
2.4 IMRT Treatment Planning
The CT images and radiotherapy structures were trans-
ferred from the initial planning CT scans to an inverse
planning system (Corvus 5.0: Nomos Corporation,
Sewickley, PA, U.S.A.), and IMRT plans were gener-
ated using 7–9 equally spaced 6-MV photon beams.
The prescribed dose was 66–70 Gy to the GTVs, 54–
60 Gy to the upper neck CTV, and 54 Gy to the lower
neck CTV, planned for delivery in a single phase using
fractions of 1.6–2 Gy for the CTVs and 2.12–2.4 Gy
for the GTVs. The planning goal was to provide ad-
equate target coverage (prescription isodose encom-
passing at least 95% of each target) while limiting
the dose to the OARs (spinal cord: <45 Gy; brain stem:
<54 Gy; parotid mean dose: <26 Gy).
For each patient, three IMRT plans were generated:
one with no margins for localization uncertainty, and
two with margins (2.5-mm, 5.0-mm) around the GTV
and CTV (resulting in PTVs) and around the spinal cord
and brain stem (PRVs). No margins were added around
the parotids and the other OARs.
2.5 Recalculation of Dose Distributions and Analysis
The beam configurations and intensity profiles of the
initial IMRT plans generated from the planning CT scans
were then applied on each repeat CT scan. The radio-
opaque fiducials placed on the thermoplastic mask
were used for isocentre alignment. Dose distributions
were recalculated, and dose–volume histograms (DVHs)
were generated for the targets and OARs. To assess dose110
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coverage, the dosimetric parameters that were ana-
lyzed included the percentage of the PTV that received
at least 100% and 95% of the prescribed dose (V100,
V95). In addition, the lowest dose to 1% of the target
volume, which can also be defined as the dose deliv-
ered to at least 99% of the volume (D99), was used to
monitor for cold spots inside the target volume.
For the spinal cord and brain stem, the maximum
dose (Dmax) and the highest dose to a volume of 1 cm3
(D1cm3) were analyzed. The mean doses (Dmean) to
the ipsilateral and contralateral parotids were used to
assess parotid sparing, and the Dmean to the larynx,
plus the D1cm3 to the mandible were also recorded.
3. RESULTS
3.1 Analysis of the Target Coverage
Table I summarizes the analysis of the target cover-
age for the initial IMRT plans and for the recalculated
dose distributions from the repeat CT scans. Note that,
for the initial IMRT plans, the values reported are for
the PTVs generated with 0-mm, 2.5-mm, and 5.0-mm
uncertainty margins, and for the repeat CT scans, val-
ues are for the GTVs and CTVs.
3.1.1 Initial IMRT Plans
The coverage of the PTVs as assessed by the mean
values of V100 and V95 was similar for the initial IMRT
plans generated without any margins and for plans
with 2.5-mm and 5.0-mm margins. However, the
mean value of D99 was lower for the upper- and lower-
neck PTVs when 5-mm margins were used. This dif-
ference probably arose because portions of these
larger PTVs overlapped with the surrounding normal
structures (such as the parotid glands), resulting in a
compromise in target coverage to achieve adequate
organ sparing. In addition, the PTVs generated by add-
ing 5.0-mm margins around the nodal-region CTVs
frequently extended into the build-up region close to
the skin surface, where the calculated dose may be
lower.
3.1.2 Repeat CT Scans
Overall, when no localization uncertainty margins
were added at the time of planning, the mean values
of V100, V95, and D99 were significantly lower for the
repeat  CT scans than for the initial IMRT plans. The
dose coverage improved for all target volumes when
PTVs were generated. Most of the benefit was seen
with the use of the 2.5-mm margins; the 5.0-mm
margins resulted in modest further improvement. The
rate of adequate target coverage, as defined by the
proportion of targets with a V100 greater than or equal
to 95% also improved with the use of PTVs. When no
margins were added for uncertainty, only 12% of the
GTVs, 54% of the upper-neck CTVs, and 25% of the
lower-neck CTVs had a V100 ³ 95%. With the use of
2.5-mm and 5.0-mm margins, this proportion in-
creased to 87.5% and 97.5% for the GTVs, and to
97.1% and 100% for the upper-neck CTVs respectively.
However, with the 2.5-mm and 5.0-mm margins alike,
only 72.7% of the lower-neck CTVs were adequately
covered by the prescription isodose. This result re-
flects significant variation in shoulder position at the
time of the repeat CT scan from the position at the
initial planning CT scan. As shown in Figure 1, the
elevation of the shoulder on the CT scan acquired
TABLE I Target coverage for the initial intensity modulated radiotherapy (IMRT) plans and repeat computed tomography (CT) scans when
0-mm, 2.5-mm, and 5.0-mm localization uncertainty margins were used a
Targets Margins (mean % ± standard deviation)
0 mm 2.5 mm 5.0 mm
Initial plan Repeat CT Initial plan Repeat CT Initial plan Repeat CT
GTV
V100
 b 95.7±0.7 85.9±9.8 95.6±0.7 96.9±4.1 95.8±1.4 99.1±1.1
V95
 b 99.9±0.2 97.4±3.9 99.8±0.2 99.6±1.0 99.7±0.4 99.9±0.1
D99
 c 98.4±0.4 94.0±3.2 97.9±1.1 98.5±2.3 97.8±2.0 99.9±1.3
CTV upper neck
V100
 b 97.6±0.4 94.7±2.9 97.5±1.0 98.4±1.3 95.4±1.4 98.7±1.2
V95
 b 99.5±0.3 97.9±1.6 99.3±0.5 99.5±0.5 98.1±0.5 99.7±0.3
D99
 c 97.3±1.2 91.0±5.6 96.0±3.1 98.9±2.8 91.4±3.2 99.7±2.2
CTV lower neck
V100
 b 96.9±1.2 88.3±8.3 97.9±1.0 94.8±5.6 96.1±0.4 96.8±4.4
V95
 b 99.4±0.3 95.1±4.5 99.3±0.3 98.5±2.2 98.5±0.4 99.4±0.9
D99
 c 97.0±1.6 85.1±10.5 98.0±1.6 95.3±5.4 90.0±7.1 98.9±3.0
a For the initial IMRT plans, values are for the planning target volume obtained by expanding the gross tumour volume (GTV) and clinical
target volume (CTV) with 0 mm, 2.5 mm, and 5.0 mm localization uncertainty margins. For the repeat CT scans (recalculated dose distribu-
tions), the values are for the GTVs and CTV, given that the localization uncertainty margins were added for planning only.
b Reported as a percentage (%) of the absolute volume.
c Reported as a percentage (%) of the prescribed dose to the GTVs and CTVs.
V100 = 100% of the prescribed dose; V95 = 95% of the prescribed dose; D99 = the dose delivered to at least 99% of the volume.CURRENT ONCOLOGY—VOLUME 13, NUMBER 3
111
GEOMETRIC UNCERTAINTIES AND PLANNING VOLUMES
during week 2 caused a major change in the shape of
the external contour at that level, resulting in increased
attenuation of the oblique beams. However, the im-
pact of positioning errors on coverage by the 95%
isodose was not as pronounced, and when 5.0 mm
margins where used, the V95 for the lower-neck CTV
was greater than or equal to 95% in all cases.
3.2 Analysis of the Dose to the OARs
Table II summarizes the analysis of the dose to the
OARs for the initial IMRT plans and of the recalculated
dose distributions from the repeat CT scans. Note that,
for the initial IMRT plans, the values of Dmax and D1cm3
for the spinal cord and brain stem are for the PRVs
generated with 0-mm, 2.5-mm, and 5.0-mm local-
ization uncertainty margins; for the repeat CT scans,
the values are for the anatomic structures only.
3.2.1 Initial IMRT Plans
The average Dmax to the spinal cord and brain stem
PRVs was slightly above the specified limit for the ini-
tial  IMRT plans generated with 2.5-mm and 5.0-mm
localization uncertainty margins. However, the dose
to the anatomic structures (without margins) was
below 45 Gy for the spinal cord and 54 Gy for the
brain stem in all plans.
Unsurprisingly, the Dmean to the parotids and lar-
ynx, and the D1cm3 to the mandible increased when
2.5-mm and 5.0-mm margins were added around the
target volumes to generate PTVs.
3.2.2 Repeat CT Scans
The Dmax to the spinal cord was greater than 45 Gy
in 57% of repeat CT scans when no PRV was used, as
compared with 35% with 2.5-mm margins and 15.4%
with 5.0-mm margins. However, the Dmax to the brain
stem was above 54 Gy in only 3.8% of the cases when
no PRV was generated and in 7.8% of the cases when
2.5-mm and 5.0-mm margins were added. A possible
explanation is that the PRVs were generated only when
similar margins were also added for the PTV. Because
of the narrower separation between the target vol-
ume and the brain stem when 2.5-mm and 5.0-mm
margins were added, the 54 Gy isodose was closer to
the brain stem for the plans with PTV and PRV than for
the plans with no margins. The highest D1cm3 to both
the spinal cord and the brain stem were below 45 Gy
and 54 Gy, respectively, for all repeat CT scans.
The Dmean to the parotids and larynx and the D1cm3
to the mandible were also higher for the recalculated
dose distributions than for the IMRT plans. The aver-
age increase in the Dmean was 1–1.5 Gy for the con-
tralateral parotid, but 2–3 Gy for the ipsilateral
FIGURE 1 For this patient, elevation of the shoulder during the repeat computed tomography (CT) scan (right) as compared with the planning
CT scan (left) resulted in reduced coverage of the lower neck region because of greater attenuation of the oblique beams. The effect on the
prescription isodose (orange) is significant, but influence on the coverage by the 90% isodose (green) is minimal.112
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parotid. The magnitude of the increase was similar
for all plans whether generated with 0-mm, 2.5-mm,
or 5.0-mm localization uncertainty margins.
4. DISCUSSION
As compared with conventional portal images, CT scan
imaging for treatment verification provides a more
accurate representation of the geometric variations
that occur during a course of head-and-neck IMRT,
including uncertainties in patient position, isocentre
localization, organ motion, and changes in external
contour because of weight loss or tumour shrinkage.
The anatomic information from the CT scan can also
be used to generate three-dimensional (3-D) dose
distributions to estimate with greater accuracy the
dose delivered to the targets and the critical struc-
tures during a fractionated course of IMRT. However,
such evaluation is labour-intensive and not without
inconveniences.
First, delineation of target volumes and OARs may
not be identical for the treatment planning CT scan
and each of the repeat CT scans acquired during treat-
ment. A recent study by Barker et al. 12 showed that
the GTVs decreased in size throughout the course of
treatment at a median rate of nearly 2% per treatment
day. Contouring variations or changes in tumour
shape or size may thus influence the DVHs for these
structures.
In our study, image-fusion techniques and stan-
dardized target volume definitions based on well-
defined anatomic landmarks 13,14 were used to
minimize contouring discrepancies between the ini-
tial planning CT scan and the repeat CT scans. As
shown in Table III, only small variations in the size of
the GTVs and CTVs occurred, except in the case of a
few positive nodes that shrank during treatment. Also,
the use of dosimetric parameters alone to assess tar-
get coverage and organ sparing may not be sufficient
for IMRT dose distributions. Analyzing DVHs does not
give information about whether an area of lower dose
is localized in the periphery or in the central region
of the target volume, or if an area of higher dose rep-
resents a clinically significant hot spot within a criti-
cal structure or instead consists of multiple hot foci
of negligible size. In addition, it is impossible to tell
if areas of dose perturbation are always located at the
same place on each of the CT scans.
However, despite these limitations, the use of CT
imaging together with 3-D dosimetric analysis con-
stitutes an effective method to study the effects of
geometric uncertainties on the dose.
Adding margins for localization uncertainty at the
time of treatment planning can effectively reduce the
hazardous effect of these variations on target cover-
age and dose to critical structures. However, the ad-
dition of margins may not compensate completely
for dose perturbation caused by a significant change
in external contour.
In fact, redesign or modification of the PTV can-
not compensate for the underdosing in the lower neck
region observed when the shoulders were not prop-
erly repositioned at the time of the repeat CT scan.
The effect of less radical changes in the shape of the
external contour, such as those related to weight loss
or tumour shrinkage, are probably not as important.
A dosimetric study by Kim et al. 15 showed that ex-
pansion and contraction of the external contour by
TABLE II Dose to organs at risk (OARs) for the initial intensity modulated radiotherapy (IMRT) plans and repeat computed tomography (CT)
scans when 0-mm, 2.5-mm, and 5.0-mm localization uncertainty margins were used
OAR Margins (mean Gy ± standard deviation)
0 mm 2.5 mm 5.0 mm
Initial plan a Repeat CT b Initial plan a Repeat CT b Initial plan a Repeat CT b
Spinal cord
Dmax 43.1±1.4 45.9±3.1 45.8±0.8 44.9±2.6 46.9±0.9 43.0±3.3
D1cm3 37.9±1.0 38.5±2.1 41.1±0.6 38.8±1.7 42.6±1.0 38.1±2.1
Brain stem
Dmax 40.8±8.1 42.1±7.4 49.5±3.9 45.6±5.9 55.6±2.6 48.4±4.0
D1cm3 33.9±8.4 34.5±8.2 41.8±5.4 35.9±6.8 49.4±3.3 41.2±4.8
Parotid contralateral
Dmean 24.4±0.6 25.9±4.0 25.6±0.5 26.7±4.4 27.7±1.5 29.2±5.4
Parotid ipsilateral
Dmean 25.8±1.6 28.1±3.3 28.6±3.8 31.4±4.3 31.2±4.5 34.0±5.4
Larynx
Dmean 30.6±1.5 33.4±2.7 32.4±32.4 35.3±3.8 36.9±2.5 39.3±3.6
Mandible
D1cm3 60.5±3.4 61.5±3.9 63.3±3.6 64.1±4.0 66.0±2.8 66.9±3.6
a Values are for the planning organ-at-risk volume (PRV) obtained by expanding the spinal cord and brain stem volume with 0 mm, 2.5 mm,
and 5.0 mm localization uncertainty margins. No PRVs were generated for the parotids, larynx, and mandible.
b Values are for the spinal cord and brain-stem volume; the localization uncertainty margins were added for planning only.
Dmax = maximum dose; D1cm3 = the highest dose to a volume of 1 cm3; Dmean = mean dose.CURRENT ONCOLOGY—VOLUME 13, NUMBER 3
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5 mm in all directions for a head-and-neck IMRT plan
does not result in significant dose perturbation for
the tumour and critical structures.
Our results also suggest that the amplitude of the
PTV required to assure ideal target coverage during
treatment may vary, depending on target volume lo-
cation, size, and shape. In our study, adding 2.5-mm
localization uncertainty margins appeared sufficient
to provide good target coverage more than 95% of
the time (V100 ³ 95%) for the upper neck CTV; 5.0-mm
margins were required to achieve the same level of
coverage for GTVs. This finding may be explained by
the fact that a given set-up error—a 3-mm misalign-
ment of the isocentre, for example—will have a
greater influence on the target coverage (as assessed
by the V100) for a positive lymph node measuring
1 cm than for the entire upper-neck region. In addi-
tion, set-up accuracy is rarely uniform through the
whole treatment volume; the importance of the geo-
metric uncertainty may vary depending on the loca-
tion of the target.
In a study by Gilbeau et al. 16, reproducibility of
the set-up was found to be significantly worse at the
level of the shoulder with the use of a thermoplastic
mask that covers the head only. A similar observa-
tion was made by Garg et al. 17, who reported that,
despite custom immobilization, the curvature of the
cervical spinal changes during the course of treat-
ment, and set-up reproducibility was inferior for
isocentres located in the low-neck region. Additional
margins for organ motion may also be required for
tumours involving the base of the tongue or the lar-
ynx 18, but such margins are probably unnecessary
for a nasopharyngeal tumour.
Proper PTV margins should not only focus on tar-
get coverage, but also consider the effect on normal-
tissue sparing. Our results showed that the Dmean to
the parotids and larynx increases when larger mar-
gins are added for PTV at the time of planning. Simi-
lar observations have also been made by van Asselen
et al. 19, who reported that the use of large PTV mar-
gins reduces parotid sparing and increases the nor-
mal-tissue complication probability for xerostomia.
Geometric variations between the planning CT scans
and the repeat CT scans also seem to influence the
mean dose to the parotids in a similar manner, with
the greater increase being observed when 5.0-mm
localization uncertainty margins are added around the
upper-neck CTV. Manning et al. 20 proposed the use
of a PRV for the contralateral parotid to compensate
for the detrimental effect of the geometric variation
on parotid sparing. Their work suggests that 5.0-mm
margins were effective in preventing the increase in
the contralateral parotid volume irradiated to 30 Gy
when the isocentre was shifted toward that side.
In addition to physical position uncertainties,
other geometric variations, such as changes in the
volume of the glands during treatment, may also in-
fluence the dose delivered to the parotids. In the study
by Barker et al. 12, the parotid glands decreased in
volume with time, at a rate of 0.6% per day, and the
centre of the glands shifted medially because of the
weight loss that occurred during treatment. Thus, sim-
ply adding PRV margins around the parotids may not
compensate properly for the overall effect of geo-
metric uncertainties on the Dmean to the parotids.
Moreover, in the study by Manning et al. 20, the use
of 5-mm PRV margins around the contralateral parotids
resulted in decreased coverage of the nodal region
adjacent to the parotids. To avoid this problem and
to limit planning complexity, we consider that PRV
should be used only for structures such as the brain
stem and spinal cord, for which the consequence of
overdosing may be serious.
In the present study, the selection of 2.5-mm and
5.0-mm margins was based mainly on the range of
the set-up errors reported for head-and-neck cancer
patients treated with custom immobilization de-
vices 15,16,21–26. Our results suggest that these mar-
gins appear to give satisfactory target coverage, but
care must be taken when generalizing about required
margins for PTV and PRV. Because the repeat CT scans
were not acquired with the patient lying on the treat-
ment couch, this study did not assess some of the
mechanical uncertainties inherent to IMRT treatment
delivery. Thus, we cannot assume that the variations
in set-up between the planning CT and each repeat CT
scan are truly representative of those encountered at
the treatment machine. Uncertainties in couch and
gantry geometry or in alignment of the lasers rela-
tive to the treatment machine isocentre may effec-
tively introduce systematic errors between the CT
planning and treatment machine set-up 27. The inte-
grated CT/LINAC unit 28,29 now allows for 3-D imaging
verification at the treatment machine, and such sys-
tems may be used for future investigations.
TABLE III Difference a in the gross tumour volume (GTV) and clinical target volume (CTV) between the repeat computed tomography (CT)
scans and the planning CT scans
GTV Upper neck Lower neck
Primary Nodal CTV CTV
Mean difference (%) +1.6±3.4 –6.0±10.0 –1.3±2.6 +1.7±4.0
a Percentage of the absolute volume, obtained by comparing the GTV and CTV volumes from the repeat CT scans with the corresponding
planning CT scan.114
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Our study did not address the issue of the
intrafractional variations attributable to patient and
internal-organ motion. However, in a study by Lee
et al. 30, 20 patients undergoing IMRT for head-and-
neck cancer had a set of orthogonal portal images
taken before and after each fraction of radiotherapy
for 3 consecutive days. Overall, the magnitude of
intrafraction patient motion was minimal (x axis:
0.4 mm + 1.2 mm; y axis: 1.2 mm + 1.6 mm; z axis:
–0.6 mm + 1.2 mm), and no persistent intrafraction
motion was observed. In another study using an in-
frared camera monitoring system, Kim et al. 31 also
found that intrafraction positioning uncertainty was
less than 2 mm for head-and-neck cancer patients
treated with IMRT. Based on these results, intrafraction
patient motion does not seem to differ significantly
from interfraction set-up uncertainty.
Finally, our results are based on a relatively low
number of repeat CT scans per patient (median: 3).
For that reason, DVHs from the 26 CT scans obtained
for the 8 patients were pooled to assess target cover-
age and dose to OARs. This population-based approach
may not reflect recurrent systematic deviations in
some patients 32. In our study, 2 patients had repeated
errors in the positioning of the shoulder, which caused
underdosing of the lower neck region; coverage for
the other patients was adequate when 2.5-mm and
5.0-mm margins were used. Additionally, because
only the repeat CT scan acquired with the same mask
and immobilization system as that used for the initial
planning CT scan were included in our analysis, we
cannot presume that our findings apply to patients
with severe weight loss or tumour shrinkage that pro-
duces changes in the surrounding tissue important
enough to affect the quality of the immobilization.
At our institution, a new mask is made whenever the
mask does not fit properly or the isocentre does not
align correctly on repeated portal verifications. One
of the problems with trying to adjust patient position
to fit more tightly within the mask is that these at-
tempts may modify the geometry of the entire neck
region relative to the isocentre, thus resulting in mis-
alignment of the beams in the some part of the treated
volume despite a somewhat adequate isocentre
alignment.
5. CONCLUSIONS
In the present investigation, the beam intensities of
initial IMRT plans were applied on repeat CT scans
obtained weekly during treatment to assess the im-
pact of geometric uncertainties on the dose distribu-
tions for head-and-neck cancer patients treated with
IMRT. Significant deviation from the prescribed dose
occurred during fractionated IMRT treatment because
of variations in patient positioning and changes in
the surrounding tissue. Adding localization uncer-
tainty margins at the time of planning to generate PTVs
and PRVs reduces the risk of underdosing targets and
overdosing the spinal cord. However, the Dmean to
both parotids and to the larynx tends to increase with
the size of the margins added for PTV. Based on our
findings, use of 5.0-mm PTV margins for the GTV and
2.5-mm PTV margins for the upper neck CTV achieves
a satisfactory compromise between target coverage
and parotid sparing.
Our results also show that, for patients treated
with comprehensive nodal IMRT, errors in shoulder
repositioning can cause significant dose perturbations
in the lower neck region despite the use of 5.0-mm
PTV margins. The use of a thermoplastic mask ex-
tending down to the level of the shoulder should be
considered in these patients to improve set-up
reproducibility.
Finally, the concept of PTV and PRV will certainly
evolve with the use of inverse planning methods for
IMRT. Integration of the geometric uncertainty in the
form of probabilistic algorithms in the optimization
process has been proposed to maximize the probabil-
ity of target coverage and OAR sparing 33. Further
quantification of the geometric variations and their
effect on the dose distribution is essential to the de-
velopment of integrated planning systems of this kind.
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